0001213900-19-001171.txt : 20190124 0001213900-19-001171.hdr.sgml : 20190124 20190124170039 ACCESSION NUMBER: 0001213900-19-001171 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190124 DATE AS OF CHANGE: 20190124 EFFECTIVENESS DATE: 20190124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kitov Pharma Ltd. CENTRAL INDEX KEY: 0001614744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-331330 FILM NUMBER: 19540534 BUSINESS ADDRESS: STREET 1: ONE AZRIELI CENTER, ROUND TOWER STREET 2: 132 MENACHEM BEGIN ROAD CITY: TEL AVIV STATE: L3 ZIP: 6701101 BUSINESS PHONE: 97239333121 MAIL ADDRESS: STREET 1: ONE AZRIELI CENTER, ROUND TOWER STREET 2: 132 MENACHEM BEGIN ROAD CITY: TEL AVIV STATE: L3 ZIP: 6701101 FORMER COMPANY: FORMER CONFORMED NAME: Kitov Pharmaceuticals Holdings Ltd. DATE OF NAME CHANGE: 20140724 D 1 primary_doc.xml X0708 D LIVE 0001614744 Kitov Pharma Ltd. ONE AZRIELI CENTER ROUND TOWER TEL AVIV L3 ISRAEL 6701101 97239333121 ISRAEL Mainrom Line Logistics Ltd. Kitov Pharmaceuticals Holdings Ltd. Other Limited company true Isaac Israel One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Chief Executive Officer and Director of the Issuer John Paul Waymack One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Chief Medical Officer and Chairman of the Board of Directors of the Issuer Simcha Rock One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director of the Issuer Steven Steinberg One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Ido Agmon One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Arye Weber One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Ran Tzror One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Revital Stern-Raff One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Independent Director of the Issuer Gil Ben-Menachem One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Vice President of Business Development and Director of the Issuer Hadas Reuveni One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Founder and Chief Technology Officer of TyrNovo, a subsidiary of the Issuer Gil Efron One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Deputy CEO and Chief Financial Officer of the Issuer Pharmaceuticals Decline to Disclose 06b false 2019-01-18 false true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10022 NJ NEW JERSEY NY NEW YORK false 6000001 6000001 0 Represents the aggregate amount received from investors in connection with Issuer's registered offering of ADSs and concurrent private placement of warrants, respectively, which were issued jointly to investors for a single purchase price. false 2 420000 true 0 Represents 6% commission and 1% management fee of gross proceeds from investors for sale of ADSs in the registered offering and concurrent private placement of warrants. We also paid or reimbursed expenses of $80,000 and issued an unregistered warrant. 0 false Kitov Pharma Ltd. /s/ Gil Efron Gil Efron Deputy CEO and Chief Financial Officer 2019-01-24